维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="Parring HH"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Effect of a multifactorial intervention on mortality in type 2 diabetes 显示文摘	Gaede P Lund-Andersen H Parring HH	2008	N Engl Med2008，358，6：	1
2	Effect of a Multifacto- rial Intervention on Mortality in Type 2 Diabetes显示文摘	Gaede P Lund-Andersen H Parring HH	2008	N Engl J Med2008，358，6：	1
3	The combination of aliskiren, a direct renin inhibitor, and losartan in patients with type 2 diabetes and nephropathy显示文摘	Parring HH Persson F Lewis JB	2008	New Engl J Med2008，358，23：	1
4	Microalbuminuria as an early marker for cardiovascular disease显示文摘	de Zeeuw D Parring HH Henning RH	2006	J Am Soc Nephrol2006，17，8：	1
5	Single versusdualblockade of the re - nin- angiotensin system in diabetic nephropathy 显示文摘	Jacobsen P Rossing K Parring HH	2004	Curr Opin Nephrol Hypertens2004，13，3：	1
6	Cardiorenal end points in a trial of aliskiren for type 2 diabetes显示文摘	Parring HH Brenner BM McMurray JJ	2012	N Engl J Med2012，367，23：	1
7	Microalbuminuria as an early marker for cardio vascular disease显示文摘	De ZD Parring HH Henning RH		0，，08：	1
8	A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes显示文摘	Lykke JA Tamow L Parring HH	2008	Scand J Clin Lab Invest2008，，：	1
9	Increased urinary albumin excretion in begin essential hypertension 显示文摘	Parring HH Jensen HE Mogensen CE	1994	Lancet1994，1，：	1
10	Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy显示文摘	Ahmed SB Hovind P Parring HH	2005	Diabetes Care2005，28，8：	1
11	Mieroalbuminuria as an early marker for cardiovascular disease 显示文摘	de Zeeuw D Parring HH Henning RH	2006	J Am SocNephrol2006，17，8：	1
12	Increased urinary albuininexcretion rate in benign essential hypertension显示文摘	Parring HH Jenser HA Mogensen CE	1974	Lancet1974，1，：	1
13	Evolving strategies for renoproteetion: diabetic Nephropathy 显示文摘	Parring HH Hovind P Rossing K	2001	Curr Opin Nephrol Hypertens2001，10，4：	1
14	The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes显示文摘	Parring HH Lehnert H Brochner-Mortensen J	2001	N Engl J Med2001，345，：	1
15	The effect of irbesartan on the development of diatetic nephropathy in patients with type 2 diabetes and microal buminuria显示文摘	Parring HH Hendrik Lehnert DM Broehner Mortensen J	2001	N Eng J Med2001，345，12：	1
16	Effet of a multifactorial intervention on mortality in type 2 diabetes 显示文摘	Gaede P Lund-Andersen H Parring HH	2008	N Engl J Med2008，358，：	1
17	Poor prognosis in pro- teinuric type 2 diabetic patients with retinopathy:insights from the RENAAL study 显示文摘	Parring HH Mogensen CE Thomas MC	2005	Q J Med2005，98，2：	1
18	Genetics of diabetic nephropathy 显示文摘	Parring HH Tarnow L Rossing P	1996	J Am Soc Nephrol1996，7，：	1
19	Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points显示文摘	Parring HH Andersen S Jacobsen P el al	2004	Seminars Nephrology2004，24，2：	1
20	Angiotensin receptor blockers in diabetic nephropathy:renal and cardiovascular end points显示文摘	Parring HH Andersen S Jacobsen P	2004	Semin Nephrol2004，24，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示